Potassium Carbonate → 7-[4-(2-ethoxyethoxy)phenyl]-1-methyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1H-1-benzazepine-4-carboxamide
反応式
B([O-])([O-])O[C:3]1[CH:8]=[CH:7][C:6]([O:9][CH2:10][CH2:11][O:12][CH2:13][CH3:14])=[CH:5][CH:4]=1.Br[C:18]1[CH:19]=[CH:20][C:21]2[N:27]([CH3:28])[CH2:26][CH2:25][C:24]([C:29]([NH:31][C:32]3[CH:37]=[CH:36][C:35]([CH2:38][N:39]([CH3:46])[CH:40]4[CH2:45][CH2:44][O:43][CH2:42][CH2:41]4)=[CH:34][CH:33]=3)=[O:30])=[CH:23][C:22]=2[CH:47]=1.C(=O)([O-])[O-].[K+].[K+]>O.C(O)C.C1(C)C=CC=CC=1.C(OCC)(=O)C.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH2:13]([O:12][CH2:11][CH2:10][O:9][C:6]1[CH:7]=[CH:8][C:3]([C:18]2[CH:19]=[CH:20][C:21]3[N:27]([CH3:28])[CH2:26][CH2:25][C:24]([C:29]([NH:31][C:32]4[CH:33]=[CH:34][C:35]([CH2:38][N:39]([CH3:46])[CH:40]5[CH2:45][CH2:44][O:43][CH2:42][CH2:41]5)=[CH:36][CH:37]=4)=[O:30])=[CH:23][C:22]=3[CH:47]=2)=[CH:4][CH:5]=1)[CH3:14]参加物
反応物 3
生成物 1
試薬・触媒・溶媒 3
実験手順
In a mixture of water:ethanol:toluene (1:1:10, v/v, 18.0 ml) were dissolved 4-(2-ethoxyethoxy)phenyl borate (315 mg) and 7-bromo-1-methyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1H-1-benzazepine-4-carboxamide (485 mg). To the solution was added potassium carbonate (332 mg), and the mixture was stirred under argon atmosphere at room temperature for 30 minutes. To the mixture was added tetrakistriphenylphosphinepalladium (46 mg), and the mixture was heated to reflux under argon atmosphere for 10 hours. The mixture was diluted with ethyl acetate, and washed with water and saturated brine, and the organic layer was dried with anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure, and the residue was purified with silica gel column chromatography (30 g, ethyl acetate:ethanol=9:1) and recrystallized from ethanol to give 7-[4-(2-ethoxyethoxy)phenyl]-1-methyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1H-1-benzazepine-4-carboxamide (Compound 9) (230 mg, 40%) as yellow crystals.
後処理
- temperaturethe mixture was heated
- temperatureto reflux under argon atmosphere for 10 hours
- washwashed with water and saturated brine
- dry with materialthe organic layer was dried with anhydrous magnesium sulfate
- customThe solvent was evaporated under reduced pressure
- customthe residue was purified with silica gel column chromatography (30 g, ethyl acetate:ethanol=9:1)
- customrecrystallized from ethanol
出典と根拠
- ORDレコード
- ord-f482a43f903445848395b54b79ad6e47
- 出典データセット
- uspto-grants-2005_08
- 特許番号
- US06936602B1
反応ノート
読み込み中…